The consumer credit market is poised for transformation driven by technological advancements, regulatory shifts, and evolving borrower expectations. Key opportunities lie in digital innovation, AI-driven underwriting, open banking, fintech collaborations, and region-specific strategies to meet increasing demand for transparent, flexible credit solutions. The consumer credit market is poised for transformation driven by technological advancements, regulatory shifts, and evolving borrower expectations. Key opportunities lie in digital innovation, AI-driven underwriting, open banking, fintech collaborations, and region-specific strategies to meet increasing demand for transparent, flexible credit solutions.
Waze has begun early testing of traffic light icons with strict limits, signalling progress on a feature users have wanted for years, though wider availability remains uncertain.The post Waze begins testing traffic light indicators in select regions appeared first on Digital Trends.
TM Forum Releases Core Network High-Reliability AN Solution Package, Leading a New Paradigm of Autonomous Networks
Travelers are warned about a viral claim that TSA agents check phones for five specific apps. This is not true. TSA officers can ask you to power on your device but do not read its contents. US Customs and Border Protection may search phones at borders, but this is rare and not limited to specific apps or seniors.
Early SHIB and AVAX investors are tracking Mutuum Finance, a $0.035 DeFi lending coin positioning for long-term growth.
The person of interest detained in Saturday’s deadly mass shooting at Brown University that left two dead and nine others injured, has been released, authorities announced. NBC’s Erin McLaughlin reports and Tom Winter joins TODAY on where the search for a suspect goes from here.
Reeds (OTCMKTS:REED – Get Free Report) and Jammin Java (OTCMKTS:JAMN – Get Free Report) are both small-cap consumer staples companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, institutional ownership, earnings and analyst recommendations. Insider & Institutional Ownership 51.5% of Reeds [...]
Faraday Future Intelligent Electric Inc. (NASDAQ:FFAI) stock rose Monday after it finalized a deposit agreement with a Florida-based operator and investor in high-end vacation rentals for 2,000 FX Super One MPVs.The arrangement includes non-refundable deposits and non-binding pre-orders, all of which have been fully collected, and Golden Hills has also joined as a paid co-creator.DetailsThis deal marks FX's entry into Florida, one of the nation's largest EV markets, expanding the company's reach to six of the eight target states in its first-phase rollout.Also Read: Full story available on Benzinga.com
JUPITER, Fla., Dec. 15, 2025 (GLOBE NEWSWIRE) -- Dyadic Applied BioSolutions ("Dyadic”) (NASDAQ: DYAI), a global biotechnology company producing precision-engineered, animal-free proteins and enzymes across life science, food & nutrition, and bioindustrial markets today announced that it has entered into a commercial agreement with Opes Diagnostics Limited ("Opes”) to support the commercial launch of Dyadic’s recombinant human transferrin, bovine transferrin, human FGF, and bovine FGF products for use in serum-free cell culture media applications in the life science, food and nutrition markets. Under the agreement, Opes will leverage its existing commercial relationships and market experience to identify and engage potential customers primarily in Europe, Israel, and Asia to accelerate market entry for Dyadic’s recombinant protein portfolio in cell culture media and related applications, while Dyadic retains the ability to sell directly and to work with additional partners globally.The collaboration is intended to accelerate the penetration of Dyadic’s recombinant protein products produced using its microbial expression platforms in industries including research, diagnostics, cultured meat and life sciences biomanufacturing that require reliable, scalable, and cost-effective sources of growth factors and functional proteins. Opes has already sampled multiple customers utilizing serum free cell culture media in life sciences, food and nutrition applications."This collaboration supports our commercial objectives by extending our recombinant protein portfolio in target markets with a partner that has strong, existing sector relationships within the sectors we serve,” said Joe Hazelton, President & COO of Dyadic Applied BioSolutions. "Opes’ market presence and customer network are expected to help drive adoption of Dyadic’s cell culture media products into expanding markets and to further our shift from primarily development activities to broader commercial engagement.”About Dyadic Applied BioSolutionsDyadic Applied BioSolutions is a global biotechnology company that uses its proprietary microbial platforms to produce recombinant proteins that are sold or licensed to partners across the life sciences, food and nutrition, and bio-industrial markets. These high-quality proteins are designed to enable customers to develop more efficient, scalable, and sustainable products. Dyadic’s C1 and DapibusTM expression systems support flexible, cost-effective manufacturing, and are the foundation of a growing portfolio of commercial and partnered programs. For more information about Dyadic, please visit www.dyadic.comAbout Opes Diagnostics LimitedOpes Diagnostics Limited is a United Kingdom-based provider of diagnostic tools, laboratory consumables, and biological reagents, with established customer relationships across Europe and other international markets. Opes offers commercialization support for a range of products used in biotechnology, diagnostics, and related fields.Safe Harbor Regarding Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act, including those regarding Dyadic’s expectations, intentions, strategies, and beliefs pertaining to future events or future financial performance, such as the success of Dyadic’s clinical trial and interest in its protein production platforms, Dyadic’s research projects and third-party collaborations, as well as the availability of necessary funding. Forward-looking statements involve many risks, uncertainties or other factors beyond Dyadic’s control. These factors include, but are not limited to, the following: (i) Dyadic’s history of net losses; (ii) market and regulatory acceptance of Dyadic’s microbial protein production platforms and other technologies; (iii) failure to commercialize Dyadic’s microbial protein production platforms or its other technologies; (iv) competition, including from alternative technologies; (v) the results of nonclinical studies and clinical trials; (vi) Dyadic’s capital needs; (vii) changes in global economic and financial conditions; (viii) Dyadic’s reliance on information technology; (ix) Dyadic’s dependence on third parties; (x) government regulations and environmental, social and governance issues; (xi) intellectual property risks; and (xii) Dyadic’s ability to comply with the listing standards of the Nasdaq Stock Market LLC. For a more complete description of the risks that could cause Dyadic’s actual results to differ from its current expectations, please see the section entitled "Risk Factors” in Dyadic’s annual reports on Form 10-K and quarterly reports on Form 10-Q filed with the SEC, as such factors may be updated from time to time in Dyadic’s periodic filings with the SEC, which are accessible on the SEC’s website and at www.dyadic.com. All forward-looking statements speak only as of the date made, and except as required by applicable law, Dyadic assumes no obligation to publicly update any such forward-looking statements for any reason after the date of this press release to conform these statements to actual results or to changes in Dyadic’s expectations.Media contacts:Dyadic Applied BioSolutions:Ping RawsonChief Financial OfficerPhone: (561) 743-8333Email: ir@dyadic.com
AI talk hits a record high.
WhatsApp Business could potentially start charging users who want to link more than four devices to the same account in a future update.
A bug in Google Messages is causing severe battery drain and overheating on some devices. Here's a temporary fix while you wait for Google to push an update.
Redmi 10 Power Price in India: Redmi has launched its new smartphone Redmi 10 Power in India. The smartphone was launched along with Redmi 10A, on Wednesday, 20 April in India
The premium Alienware m15 R7 and m17 R5 highlight four new Ryzen-powered systems.
Apple is offering its new firmware update for the MagSafe accessory that promises to give you faster charging for the compatible iPhone models.
System apps with native call-recording functionality remain unaffected.
The OnePlus Nord 2T India launch may take place soon as the moniker has been spotted on the TDRA certification. The OnePlus Nord 2T's camera details have also been leaked. Here are the expected specifications of the device.
The iPhone 16 is likely to be the first Apple device to skip the camera notch.
Garena Free Fire Max redeem codes are 12-digit codes that are region-specific and can be used by players to gain an edge over rivals in every round of the battle royale game.
We are still not sure that no-charger policy will be limited to Narzo 50A Prime or it will be extended to other Realme budget, mid-segment and premium phones
